Virginia Retirement Systems Et Al Allakos Inc. Transaction History

Virginia Retirement Systems Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 17, 2023	BUY	$5.66 - $8.42 $90,560 - $134,720	16,000 New	16,000 $135 Million
Q2 2021 Aug 13, 2021	SELL	$85.37 - $114.1 $273,184 - $365,120	-3,200 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$109.73 - $153.66 $87,784 - $122,928	-800 Reduced 20.0%	3,200 $367,000
Q4 2020 Feb 16, 2021	SELL	$79.58 - $152.45 $87,538 - $167,695	-1,100 Reduced 21.57%	4,000 $560,000
Q3 2020 Nov 12, 2020	BUY	$66.43 - $90.99 $19,929 - $27,297	300 Added 6.25%	5,100 $415,000
Q2 2020 Aug 12, 2020	BUY	$44.04 - $80.69 $211,392 - $387,312	4,800 New	4,800 $345,000

68.8M

20.9K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $22M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.